Abstract The positive association of adult height with breast cancer (BC) risk has been hypothesized to be partly accounted for by an association of this risk with maternal height (operating in utero to modify hormone effects). In a case-control study (271 BC patients and 791 controls) nested within the EPIC-Greece cohort, we applied mediation analysis to calculate the direct and indirect (through the woman's own height) effect of maternal height on BC risk. Per 5 cm increase in maternal height and depending on its reference value: the indirect effect odds ratio ranges from 1.02 to 1.07; the direct effect odds ratio from 1.06 to 1.11; and the total (direct and indirect effects) from 1.08 to 1.19. The effect sizes consistently increased for higher reference categories of maternal height, but did not generally reach statistical significance, possibly due to the limited sample size.
Height has been positively associated with breast cancer risk [1] . In 1990, Trichopoulos [2] published a hypothesis implicating in utero exposures in breast cancer etiology, which has been supported by the effects of the in utero exposure to diethylstilbestrol (a synthetic estrogen) on offspring breast cancer risk [3] , as well as studies showing a positive association of birth size (a proxy for in utero exposures) with this risk [4] . The underlying mechanism has been reported to rely on the effect of pregnancy growth hormones on the size of the fetus' mammary tissue-specific stem cell pool [5] . On the basis of the above, it has been hypothesized that the positive association of adult height with breast cancer risk may, to a certain extent, be accounted for by an association between maternal height (operating in utero to modify the effects of growth hormones on the fetal stem cell pool) and the risk of breast cancer. [6] We conducted a case-control study nested within the Greek segment of the European Prospective Investigation into Cancer (EPIC) [7] , to investigate whether maternal height is also associated with breast cancer risk and, if so, to which extent this association is mediated through the woman's own height. Anthropometric measurements (including height) were performed for all volunteers in EPICGreece at recruitment; for the present study, we additionally collected information on maternal height in a subsample of the women through telephone interviews conducted July-September 2012. We included both prevalent (192) and incident (244) breast cancer cases in the EPIC-Greece cohort and matched them to three control women, who had not developed any type of cancer. Matching criteria were age at recruitment (±1 year) and date of enrollment (±6 months). Cases and controls had to be alive at the time of interview on maternal height. The percentage of those who didn't answer declined to participate was 33% for the cases and we tried to find up to 3 controls for them (the percentage of non-repliers in controls was about the same with the cases, but we tried to substitute the non-repliers). After excluding 74 participants (6%) with missing information in any of the covariates used in our analyses, we ended up with 271 breast cancer cases (60 of them being only self-reported canes, all the others were confirmed through hospital records) and 791 controls (see Table 1 ).
Breast cancer cases were defined as those with a verified (through hospital discharge data or medical records) breast cancer diagnosis (International Classification of Diseases for Oncology code C50). Sociodemographic, lifestyle and reproductive history data were collected at recruitment in EPIC-Greece, through standard interviewer-administered questionnaires. Regarding maternal height, women were asked to classify their mother's height in comparison to their own height in one of five categories: shorter by C8 cm, 3-7 cm shorter, approximately the same height (±2 cm), 3-7 cm taller, taller by C8 cm. They were also asked to give information of their mother's height in cm.
We applied causal mediation analysis methods for dichotomous outcomes [8] and we estimated the natural direct effect of maternal height on breast cancer risk, the natural indirect effect through the woman's own height, as well as the total effect (a combination of the two). Given that the outcome is dichotomous, natural direct and indirect effects were measured at the odds ratio (OR) scale, and the total effect was estimated by the multiplication of these two [8] . To derive the results from the mediation analysis, per 5 cm increase in maternal height (continuously), at different reference levels of this variable, we ran two models: a) logistic regression, to model the association of maternal height, woman's own height and other potential confounders with breast cancer risk; in this model, we allowed for interaction between maternal and woman's own height, and b) linear regression, applied only to controls, to model the dependence of a woman's own height on maternal height and the remaining potential confounders. Conditional natural direct, indirect and total effects of maternal height on breast cancer risk were estimated at the mean value of the confounders among controls. The potential (mediator-outcome) confounders we accounted for in our analysis were age at enrollment, body mass index, alcohol intake, energy intake, physical activity, number of children, age at menarche, smoking and menopausal status. Statistical analyses were conducted using the Stata Statistical Software, release 11 (StataCorp. 2009, StataCorp LP). For the mediation analysis, we used the paramed command.
In Table 2 , the (conditional) natural direct, indirect and total effects of maternal height on breast cancer risk are expressed as ORs per 5 cm increase in maternal height, at different reference levels of maternal height. Hence, per 5 cm increase in maternal height and depending on the reference value of maternal height: the indirect effect odds ratio ranges from 1.02 to 1.07; the direct effect odds ratio ranges from 1.06 to 1.11; for the total effect, combining both direct and indirect effects, the odds ratio ranges from 1.08 to 1.19. The results from the regression models used for this mediation analysis are presented in Tables 3 and 4 (see ''Appendix''). The effect size of the association, overall, as well as through either the direct or the indirect route, appears to be higher as maternal height increases, as a reflection of a positive exposure-mediator interaction (see Table 3 in the ''Appendix''). When we repeated the analyses: (a) among individuals for whom the information on height collected in categories was consistent with that provided as exact height (1001 of the 1062 of the participants, i.e. 94%), (b) for incident breast cancer cases only (i.e. after excluding prevalent cases and their corresponding controls (c) among postmenopausal women, (d) with no adjustment for any of the potential confounders, and (e) among the confirmed cases and the corresponding controls; the results remained practically unchanged, but slightly more pronounced associations in scenarios (a) and (e), i.e. when we used stricter criteria (see ''Appendix'', Tables 5, 6, 7, 8, 9) . Notwithstanding their consistency in sensitivity analyses, our results did not generally reach statistical significance, possibly due to our limited sample size.
The results are suggestive of a direct effect of maternal height on breast cancer risk, as well as an indirect effect (mediated through a woman's own height). The underlying mechanism of the early life origins of breast cancer hypothesis [2] has been reported to rely on the effect of pregnancy growth hormones on the size of the fetal mammary tissue-specific stem cell pool [5] . Interestingly so, it has been reported in cohorts of Caucasian and Asian women, that the associations of pregnancy growth-enhancing hormones-notably maternal estriol, as well as cord blood insulin-like growth factor 1 (IGF-1) and IGF-2-with birth size were mostly evident among the offspring of taller mothers [9] . On the basis of these associations, maternal height appears to play a role in the intrauterine origin of breast cancer. It can, thus, be inferred that among taller mothers, maternal size does not impose constraints on fetal growth, thus allowing growth-enhancing pregnancy hormones to exercise their growth potential and be positively associated with birth size and, thus, the risk of breast cancer [6] . In 2015, Vatten and colleagues studied a cohort of women in Norway and reported a positive association of birth length with breast cancer risk, which was stronger among women whose mothers were relatively tall (median or taller) compared to women whose mothers were relatively short (below median) at childbearing [10] . The results of the Norwegian cohort are in line with the results reported in our study in supporting a role of maternal height in breast cancer aetiology.
Strengths of our study include its being nested within the established and well-described EPIC-Greece cohort [7] and the novel approach of causal mediation analysis. Regarding the limitations, maternal height had to rely on recall data and misclassification cannot be excluded; nevertheless, it is unlikely that this misclassification was differential. We also included prevalent breast cancer cases, as both the exposure and the mediator are not affected by prevalent events, i.e. reverse causation is not an issue. Moreover, we did not include in the analyses individuals who were deceased at the time of interviews about maternal height or refused to participate; however, it is reasonable to assume that those participants were missing at random. Regarding the mediation analysis, the criticism expressed about the assumption that no effect of the exposure confounds the mediatoroutcome relation (the cross-world independence assumption) could apply also to our study [8] . Additionally, we could not adjust for the exposure-mediator or the exposureoutcome confounders (e.g. mother's socioeconomic status), but it is unlikely that this would have greatly affected our results. Finally, the study population was of moderate size and the numbers were adequate to generate strongly suggestive, though not statistically significant results.
In conclusion, we found evidence in support of a role of maternal height, both direct and indirect through a woman's own height, in breast cancer etiology. If replicated, our results will allow us to move one step forward in our understanding of the early life origins of breast cancer and, perhaps also, the early life origins of other cancers that have been positively associated with adult height. ), alcohol intake (in g/day), energy intake (in kcal/day), physical activity (in METS/day), number of children, age at menarche (in years), smoking status (never, former and current smokers; categorically) and menopausal status (pre-and peri-menopausal versus post-menopausal women)
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Study population
Though anthropometric measurements (including height) were performed and recorded for the volunteers in EPICGreece (11,953 men/16,619 women) [11] , no information was recorded on the height of the participants' mothers. As collection of this information for all women recruited in EPIC-Greece was impractical, we conducted a matched case-control study nested within EPIC-Greece and collected information on maternal height in a subsample of the women in the cohort through telephone interviews. We included all breast cancer cases diagnosed either before or after their recruitment in the cohort. Each breast cancer case was matched to three control women, who had not developed any type of cancer. Matching criteria were age at recruitment (±1 year) and date of enrollment (±6 months). Cases and controls had to be alive at the time of interview on maternal height. Of the 524 cases, 436 (96%) respectively, were alive at the time of the interview. The percentage of those who didn't answer or declined to participate was 33% (144 individuals) for the cases and we tried to find up to 3 controls for them (the percentage of non-repliers in controls was about the same with the cases, but we tried to substitute the non-repliers). We collected information from 1136 women and, after excluding 74 participants (6%) with missing information in any of the covariates used in our analyses, we ended up with 271 breast cancer cases (110 prevalent and 161 incident cases) and 791 controls. Moreover, 60 out of the 271 breast cancer cases were only self-reported canes and not confirmed through hospital records).
Data collection
Socio-demographic and lifestyle characteristics, such as educational level, physical activity, smoking status, as well as information related to age at menarche, menopausal status and parity, were recorded at enrollment in the EPICGreece cohort. Recording frequency and duration of participation in physical activities [11] allowed the calculation of a metabolic equivalent index (MET value) for each activity [12] and eventually of an overall MET 9 hour sum, indicating the amount of energy per kilogram of body weight expended during an average day by each participant. Dietary habits were also recorded at enrollment, with the use of a validated interviewer-administered semiquantitative food frequency questionnaire [13] . Anthropometric measurements were undertaken using standardized procedures [14] . Body weight was measured to the nearest 100 g, and height was measured to the nearest 1 cm. Body mass index (BMI) was calculated as the ratio of weight over the square of height (in kg/m 2 ). Data on maternal height were collected through telephone interviews conducted from July to September 2012. Women were asked to classify their mother's height in comparison to their own height in one of five categories: shorter by 8 cm or more, 3-7 cm shorter, approximately the same height (±2 cm), 3-7 cm taller, taller by 8 cm or more. They were also asked to give an estimation of their mother's height in cm.
Sensitivity analyses
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